The effect of cardiac rehabilitation on HIF1a gene expression and plasma levels of BFGF and PGC1a in coronary patients after CABG

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191228045919N1

Enrollment

Registered

2020-01-01

Start date

2019-10-08

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis and CABG practice. ?????????? ? ??? CABG

Interventions

Intervention group: Aerobic and resistance training.

Eligibility

Sex/Gender

Male

Age

45 Years to 60 Years

Inclusion criteria

Inclusion criteria: Having no systolic blood pressure greater than 160 mmHg and diastolic higher than 100 mmHg

Exclusion criteria

Exclusion criteria: No use of walking aids such as canes and walkers

Design outcomes

Primary

Measure	Time frame
?¬ HIF1 gene expression. Timepoint: Blood sampling in the pre-test phase 24 hours before the first training session and 48 hours after the last training session. Method of measurement: Blood sampling from brachial vein and testing by Real-Time-PCR.;PGC1a. Timepoint: Blood sampling in the pre-test phase 24 hours before the first training session and 48 hours after the last training session. Method of measurement: Blood sampling from the bra vein and the use of a special laboratory kit.;BFGF. Timepoint: Blood sampling in the pre-test phase 24 hours before the first training session and 48 hours after the last training session. Method of measurement: Blood sampling from the bra vein and the use of a special laboratory kit.	—

Measure

Time frame

?¬ HIF1 gene expression. Timepoint: Blood sampling in the pre-test phase 24 hours before the first training session and 48 hours after the last training session. Method of measurement: Blood sampling from brachial vein and testing by Real-Time-PCR.;PGC1a. Timepoint: Blood sampling in the pre-test phase 24 hours before the first training session and 48 hours after the last training session. Method of measurement: Blood sampling from the bra vein and the use of a special laboratory kit.;BFGF. Timepoint: Blood sampling in the pre-test phase 24 hours before the first training session and 48 hours after the last training session. Method of measurement: Blood sampling from the bra vein and the use of a special laboratory kit.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactazar hamidi

Islamic Azad University

azar.hamidi57@gmail.com00985255225630

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 17, 2026